Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Technical Sales Positions No Longer On Crossflo Site

Jump:

If by "outside investors" you mean institutional investors, my opinion is that the type of institutional investors with any substance will not look seriously at PTSC until we have turned the corner toward positive and repeatable revenues and have moved up and off of the OTC exchange.

Also in my opinion, I have been noticing a marshaling of resources behind Crossflo. They are at their now-or-never point, and will need to push into their target markets by year's end or so, and they will need to turn a profit. If this occurs, and it grows over the next year or so, we may see the positive time we all desire. Then again, it could all fail, and therein lies the subjectivity. Nobody can predict the outcome with certainty, but I find optimism in the experience of RG and others such as Donald Schrock, and their past successes.

Thank you for asking my opinion, and good luck to us all.

Cheers,

DG

Share
New Message
Please login to post a reply